CA2347080A1 - Gene 12 lie au recepteur de tnf (tnfr) - Google Patents
Gene 12 lie au recepteur de tnf (tnfr) Download PDFInfo
- Publication number
- CA2347080A1 CA2347080A1 CA002347080A CA2347080A CA2347080A1 CA 2347080 A1 CA2347080 A1 CA 2347080A1 CA 002347080 A CA002347080 A CA 002347080A CA 2347080 A CA2347080 A CA 2347080A CA 2347080 A1 CA2347080 A1 CA 2347080A1
- Authority
- CA
- Canada
- Prior art keywords
- polypeptide
- seq
- polypeptides
- sequence
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Abstract
La présente invention a trait à une nouvelle protéine humaine appelée gène 12 lié au TNFR, et à des polynucleotides isolés qui codent pour cette protéine. L'invention concerne également des vecteurs, des cellules hôtes, des anticorps et des procédés de recombinaison servant à produire cette protéine humaine. L'invention concerne en outre des méthodes diagnostiques et thérapeutiques utiles pour diagnostiquer et traiter des affections liées à cette nouvelle protéine humaine.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10495098P | 1998-10-20 | 1998-10-20 | |
US60/104,950 | 1998-10-20 | ||
PCT/US1999/024413 WO2000023572A1 (fr) | 1998-10-20 | 1999-10-19 | Gene 12 lie au recepteur de tnf (tnfr) |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2347080A1 true CA2347080A1 (fr) | 2000-04-27 |
Family
ID=22303299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002347080A Abandoned CA2347080A1 (fr) | 1998-10-20 | 1999-10-19 | Gene 12 lie au recepteur de tnf (tnfr) |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1121419A4 (fr) |
JP (1) | JP2002527104A (fr) |
AU (1) | AU6433499A (fr) |
CA (1) | CA2347080A1 (fr) |
WO (1) | WO2000023572A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6605699B1 (en) | 1997-01-21 | 2003-08-12 | Human Genome Sciences, Inc. | Galectin-11 polypeptides |
CN1328017A (zh) * | 2000-06-12 | 2001-12-26 | 上海博德基因开发有限公司 | 一种新的多肽——人含细胞色素c结构域的tnfr/ngfr蛋白12和编码这种多肽的多核苷酸 |
CN1329086A (zh) * | 2000-06-21 | 2002-01-02 | 上海博德基因开发有限公司 | 一种新的多肽——人含细胞色素c结构域的tnfr/ngfr蛋白15和编码这种多肽的多核苷酸 |
JPWO2002062852A1 (ja) * | 2001-02-05 | 2004-06-10 | 中外製薬株式会社 | 細胞上に発現する受容体タンパク質 |
WO2003011320A1 (fr) * | 2001-08-02 | 2003-02-13 | Genset S.A. | Agonistes et antagonistes d'obesingen dans le traitement des troubles metaboliques |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020025551A1 (en) * | 1998-04-09 | 2002-02-28 | Millennium Pharmaceuticals, Inc., A Delaware Corporation | Novel molecules of the t129-related protein family and uses thereof |
-
1999
- 1999-10-19 CA CA002347080A patent/CA2347080A1/fr not_active Abandoned
- 1999-10-19 AU AU64334/99A patent/AU6433499A/en not_active Abandoned
- 1999-10-19 JP JP2000577283A patent/JP2002527104A/ja not_active Withdrawn
- 1999-10-19 WO PCT/US1999/024413 patent/WO2000023572A1/fr not_active Application Discontinuation
- 1999-10-19 EP EP99952028A patent/EP1121419A4/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2000023572A1 (fr) | 2000-04-27 |
JP2002527104A (ja) | 2002-08-27 |
EP1121419A4 (fr) | 2003-02-05 |
AU6433499A (en) | 2000-05-08 |
EP1121419A1 (fr) | 2001-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6593112B1 (en) | Polynucleotides encoding fibroblast growth factor 15 | |
US6566325B2 (en) | 49 human secreted proteins | |
US20030077809A1 (en) | 97 human secreted proteins | |
US20080051338A1 (en) | 98 Human Secreted Proteins | |
US20070224121A1 (en) | Connective Tissue Growth Factor-4 | |
CA2323776C (fr) | Analogue de chaine gamma commune de recepteur de cytokine | |
US6982320B2 (en) | Cytokine receptor common gamma chain like | |
US20040048294A1 (en) | 31 human secreted proteins | |
US6605441B1 (en) | Antibodies against fibroblast growth factor 11 | |
CA2355363A1 (fr) | Facteur-2 stimulant de prostacycline | |
US20040030115A1 (en) | 31 human secreted proteins | |
US7012134B2 (en) | Dendritic enriched secreted lymphocyte activation molecule | |
US20030065139A1 (en) | Secreted protein hmmbd35 | |
US6632920B1 (en) | 36 human secreted proteins | |
US20040181047A1 (en) | 33 human secreted proteins | |
US20040225118A1 (en) | 31 human secreted proteins | |
US20030022277A1 (en) | Human neuropeptide receptor | |
CA2347080A1 (fr) | Gene 12 lie au recepteur de tnf (tnfr) | |
US6620912B2 (en) | Dendritic enriched secreted lymphocyte activation molecule | |
US20020025553A1 (en) | Transforming growth factor alpha HIII | |
US6365369B1 (en) | Prostate specific secreted protein | |
EP1206541A1 (fr) | Molecule d'activation lymphocytaire secretee de maniere enrichie par des cellules dendritiques | |
US20020098541A1 (en) | TNFR related gene 12 | |
US20030082532A1 (en) | Tumor necrosis factor receptor related gene 12 polypeptides | |
CA2359132A1 (fr) | Proteine specifique de la moelle osseuse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |